Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06822647 · ClinicalTrials.gov registry record · NA

Optimal Timing of Routine Cervical Length Measurements During Anatomy Survey

A NA study of Preterm Birth and Cervical Insufficiency, sponsored by Henry Ford Health System.

Recruiting
Registry status
NA
Development phase
550
Enrollment target
1
Study location

NCT06822647: Recruiting NA study of Preterm Birth and Cervical Insufficiency, sponsored by Henry Ford Health System.

NCT06822647 is a NA study of Preterm Birth and Cervical Insufficiency that is actively recruiting participants, run by Henry Ford Health System. The registered enrollment target is 550 participants, below the 4,395-participant average among 39 other Preterm Birth trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06822647, a NA study of Preterm Birth and Cervical Insufficiency, is actively recruiting participants, sponsored by Henry Ford Health System.

RECRUITING
Registry status
NA
Development phase
550 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to determine the optimal timing for measuring cervical length (CL) during fetal anatomy surveys in pregnant individuals. This study focuses on improving the accuracy of cervical length assessments, which are critical for identifying individuals at risk for preterm birth. The main questions it aims to answer are: * Does measuring cervical length at the beginning of the anatomy survey result in a higher proportion of scans meeting the nine CLEAR (Cervical Length Education and Review) criteria compared to measuring at the end of the survey? * Does the use of sepia-filtered ultrasound images improve the proportion of scans meeting the nine CLEAR criteria compared to conventional grayscale images? Researchers will compare two groups of participants randomized to have cervical length measured either at the beginning or at the end of the anatomy survey. Additionally, all participants will undergo cervical length measurements using both grayscale and sepia-filtered ultrasound imaging. Participants will: * Receive a patient information sheet through MyChart explaining the study and standard cervical length screening during anatomy surveys. * Provide verbal consent for a transvaginal ultrasound and study participation. * Be randomized to have their cervical length measured at either the start or end of the fetal survey. * Undergo cervical length measurement using both grayscale and sepia-filtered ultrasound imaging modalities. * This study involves no additional risks beyond those of routine clinical care and aims to enhance clinical practice by identifying optimal methods for cervical length assessment during pregnancy.

Primary Outcome

The primary outcome is the proportion of transvaginal cervical length measurements that meet all nine CLEAR (Cervical Length Education and Review) criteria for accuracy. This will assess whether timing (beginning vs. end of anatomy survey) impacts measurement reliability.

Conditions Studied

Preterm Birth Cervical Insufficiency Cervical Length Measurement

Interventions

  • PROCEDURE Cervical Length Measurement at the Beginning of the Anatomy Survey
  • PROCEDURE Cervical Length Measurement at the End of the Anatomy Survey

Study Locations (1)

Michigan

  • Henry Ford Health New Center One - Detroit

Trial Details

FieldValue
Enrollment Target 550 participants
Start Date 2025-01-20
Est. Completion 2027-07-01
Phase NA
Henry Ford Health System

234 total trials

What NCT06822647 shows while recruiting

NCT06822647 is an interventional study that assigns participants to a tested intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, below the 4,395-participant average among 39 other Preterm Birth trials with a reported enrollment target (87% lower).

The record links to 3 conditions, with Preterm Birth appearing as the primary indexed condition, and to 2 interventions - of which Cervical Length Measurement at the Beginning of the Anatomy Survey is the first listed.

NCT06822647 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06822647 about?

NCT06822647 is a clinical study titled "Optimal Timing of Routine Cervical Length Measurements During Anatomy Survey". The goal of this clinical trial is to determine the optimal timing for measuring cervical length (CL) during fetal anatomy surveys in pregnant individuals. This study focuses on improving the accuracy of cervical length assessments, which are critical for identifying individuals at risk for preterm ...

What is the current status of trial NCT06822647?

This trial is currently recruiting. It is a NA study. The enrollment target is 550 participants. The study started on 2025-01-20. Estimated completion is 2027-07-01.

What conditions does trial NCT06822647 study?

This clinical trial studies the following conditions: Preterm Birth, Cervical Insufficiency, Cervical Length Measurement.

What interventions are being tested in trial NCT06822647?

The interventions under investigation include: Cervical Length Measurement at the Beginning of the Anatomy Survey (PROCEDURE), Cervical Length Measurement at the End of the Anatomy Survey (PROCEDURE).

Who is sponsoring clinical trial NCT06822647?

This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06822647 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Preterm Birth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06822647's enrollment target sits among peer trials

550 12th of 39 higher than 27 of 39 other Preterm Birth trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Preterm Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01852448 · 550 participants

    Genetics of Insulin and Incretins in Cystic Fibrosis

  • NCT02995252 · 550 participants

    The HOPE Study: Characterizing Patients With Hepatitis B and C

  • NCT03474913 · 550 participants

    Upright MRI for Prostate Cancer Screening

  • NCT04761120 · 550 participants

    Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06822647

Source: ClinicalTrials.gov NCT06822647, the US trial registry maintained by the National Library of Medicine. NCT06822647 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.